DashboardPortfoliosWatchlistCommunityDiscoverScreener
Header cover image
  • Investing Ideas
  • /
  • Global Pharmaceuticals & Biotech Insider-Bought Value Plays

Global Pharmaceuticals & Biotech Insider-Bought Value Plays

Results

89

1 new
  • Global
  • United States
  • Australia
  • United Kingdom
  • Canada
  • India
  • China
  • Argentina
  • Austria
  • Bahrain
  • Bangladesh
  • Belgium
  • Bermuda
  • Botswana
  • Brazil
  • Bulgaria
  • Chile
  • Colombia
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Egypt
  • Estonia
  • Finland
  • France
  • Germany
  • Ghana
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kenya
  • Kuwait
  • Latvia
  • Lithuania
  • Luxembourg
  • Malawi
  • Malaysia
  • Malta
  • Mauritius
  • Mexico
  • Morocco
  • Namibia
  • Netherlands
  • New Zealand
  • Nigeria
  • Norway
  • Oman
  • Pakistan
  • Palestinian Authority
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Qatar
  • Romania
  • Russia
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • South Korea
  • Spain
  • Sri Lanka
  • Sweden
  • Switzerland
  • Taiwan
  • Tanzania
  • Thailand
  • Trinidad & Tobago
  • Tunisia
  • Turkey
  • Uganda
  • Ukraine
  • United Arab Emirates
  • Venezuela
  • Vietnam
  • Zambia
  • Zimbabwe
  • Any
  • Automobiles
  • Banks
  • Capital Goods
  • Commercial Services
  • Consumer Durables
  • Consumer Services
  • Diversified Financials
  • Energy
  • Consumer Retailing
  • Food, Beverage & Tobacco
  • Healthcare
  • Household
  • Insurance
  • Materials
  • Media
  • Pharmaceuticals & Biotech
  • Real Estate
  • Retail
  • Semiconductors
  • Software
  • Tech
  • Telecom
  • Transportation
  • Utilities

89 companies

Imeik Technology DevelopmentLtd

Market Cap: CN¥27.0b

Engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China.

300896

CN¥89.47

7D

2.1%

1Y

-52.1%

PharmaResearch

Market Cap: ₩3.4t

Operates as a biopharmaceutical company primarily in South Korea.

A214450

₩327,500.00

7D

-4.2%

1Y

-45.1%

Consun Pharmaceutical Group

Market Cap: HK$11.2b

Produces and sells pharmaceutical products in Mainland China.

1681

HK$13.31

7D

2.1%

1Y

-18.0%

Hypera

Market Cap: R$16.8b

Operates as a pharmaceutical company in Brazil.

HYPE3

R$23.80

7D

4.6%

1Y

-0.9%

Tianjin Ringpu Bio-TechnologyLtd

Market Cap: CN¥7.6b

Engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products.

300119

CN¥16.76

7D

-2.7%

1Y

-23.6%

Anhui Sunhere Pharmaceutical ExcipientsLtd

Market Cap: CN¥3.0b

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.

300452

CN¥12.77

7D

1.3%

1Y

-3.1%

Vext Science

Market Cap: CA$61.9m

Through its subsidiaries, engages in integrated cannabis operations in the United States.

VEXT

CA$0.26

7D

-3.8%

1Y

-13.6%

SkinBioTherapeutics

Market Cap: UK£20.1m

A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.

SBTX

UK£0.077

7D

-16.2%

1Y

-53.3%

Forum Markets

Market Cap: US$63.3m

A financial technology company, develops a blockchain-based platform focused on the acquisition, structuring, and tokenization of real-world assets worldwide.

FRMM

US$4.66

7D

2.0%

1Y

-81.6%

Planet 13 Holdings

Market Cap: CA$65.4m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

PLTH

CA$0.18

7D

-2.6%

1Y

-37.3%

Beijing Strong BiotechnologiesInc

Market Cap: CN¥6.7b

Researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally.

300406

CN¥11.40

7D

1.3%

1Y

-15.6%

HansBiomed

Market Cap: ₩258.4b

Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.

A042520

₩18,120.00

7D

-8.2%

1Y

13.4%

Maccura BiotechnologyLtd

Market Cap: CN¥5.5b

Engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally.

300463

CN¥9.08

7D

1.2%

1Y

-22.9%

Dong-A Socio Holdings

Market Cap: ₩629.9b

Engages in the pharmaceutical business in South Korea.

A000640

₩93,600.00

7D

3.2%

1Y

-17.0%

Verrica Pharmaceuticals

Market Cap: US$79.9m

A dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States.

VRCA

US$4.45

7D

-9.4%

1Y

1.4%

Square Pharmaceuticals

Market Cap: ৳189.5b

Manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally.

SQURPHARMA

৳213.80

7D

-0.3%

1Y

-2.8%

CSPC Pharmaceutical Group

Market Cap: HK$101.9b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

1093

HK$8.93

7D

2.5%

1Y

-10.2%

Shijiazhuang Yiling Pharmaceutical

Market Cap: CN¥25.4b

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

002603

CN¥15.20

7D

0.07%

1Y

-7.7%

Sichuan Kelun Pharmaceutical

Market Cap: CN¥63.3b

Researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally.

002422

CN¥39.77

7D

1.1%

1Y

9.2%

Diaceutics

Market Cap: UK£144.3m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

DXRX

UK£1.70

7D

7.6%

1Y

13.3%

Dr. Reddy's Laboratories

Market Cap: ₹975.5b

Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.

500124

₹1,171.10

7D

0.9%

1Y

-11.5%

Rubicon Organics

Market Cap: CA$30.7m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

ROMJ

CA$0.48

7D

0%

1Y

-18.6%

BICO Group

Market Cap: SEK 1.6b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

BICO

SEK 22.25

7D

8.8%

1Y

5.7%

Fortress Biotech

Market Cap: US$83.7m

Operates as a biopharmaceutical company in the United States and internationally.

FBIO

US$2.51

7D

-0.4%

1Y

-31.6%

China Medical System Holdings

Market Cap: HK$26.9b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

867

HK$11.07

7D

2.7%

1Y

-26.3%

Hunan Fangsheng Pharmaceutical

Market Cap: CN¥4.6b

Engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China.

603998

CN¥10.39

7D

2.2%

1Y

-3.6%

Viva Biotech Holdings

Market Cap: HK$3.0b

An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.

1873

HK$1.47

7D

14.5%

1Y

-43.2%

Daihan PharmaceuticalLtd

Market Cap: ₩155.2b

Engages in the manufacture and sale of therapeutic drugs in South Korea.

A023910

₩26,400.00

7D

-0.9%

1Y

-11.6%

Organogenesis Holdings

Market Cap: US$175.0m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

ORGO

US$1.42

7D

-4.7%

1Y

-69.0%

Kyung Dong Pharmaceutical

Market Cap: ₩147.4b

Manufactures and sells pharmaceuticals in South Korea.

A011040

₩5,030.00

7D

-1.0%

1Y

-14.5%

L&C BIOLTD

Market Cap: ₩1.2t

Operates as a research and development company in tissue regeneration medicine.

A290650

₩46,100.00

7D

-2.8%

1Y

-15.1%

Hainan Huluwa Pharmaceutical Group

Market Cap: CN¥2.3b

Hainan Huluwa Pharmaceutical Group Co., Ltd.

605199

CN¥5.77

7D

-2.0%

1Y

-36.5%

Ilyang PharmaceuticalLtd

Market Cap: ₩141.2b

Operates as a pharmaceutical company primarily in South Korea.

A007570

₩7,880.00

7D

-2.4%

1Y

-39.6%

Vita Life Sciences

Market Cap: AU$156.2m

A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.

VLS

AU$2.77

7D

0.4%

1Y

6.5%

Sprint Bioscience

Market Cap: SEK 311.3m

A pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.

SPRINT

SEK 2.95

7D

7.7%

1Y

424.9%

Arterra Bioscience

Market Cap: €20.4m

A research-based biotech company, engages in the research and development of various ingredients and natural solutions.

ARBS

€3.06

7D

2.0%

1Y

10.9%

Page 1 of 3

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide